India, Sept. 8 -- With heightened trade tensions between the U.S. and Canada and rising oil prices weighing on investor sentiment, U.S. stocks came under pressure on Tuesday. Against this backdrop, the SPDR S&P Biotech ETF (XBI), a broad benchmark for the U.S. biotechnology sector, declined 1.15% during regular trading hours but edged 0.09% higher in overnight trading.
Now, let's take a look at some of the biotech and pharmaceutical companies that gained in overnight trading on Tuesday.
Modular Medical Inc. (MODD), a medical device company, which plunged more than 23% during regular trading on Tuesday, was up over 13% in overnight trading.
The company plans to launch its next-generation Pivot tubeless patch pump in five U.S. markets - At...